Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.

Antimicrobial Agents and Chemotherapy
Olle AspevallBo Svenungsson

Abstract

All 238 Clostridium difficile isolates were susceptible to metronidazole and vancomycin, whereas 84% and 1% were resistant to clindamycin and fusidic acid. Etest MICs for metronidazole were lower than agar dilution MICs (P < 0.01) but without difference in susceptible-intermediate-resistant categorization. No particular PCR ribotype was associated with clindamycin or fusidic acid resistance.

References

Nov 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S Tabaqchali, M Wilks
Jan 26, 1989·The New England Journal of Medicine·L V McFarlandW E Stamm
Feb 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M H SamoreA W Karchmer
Feb 10, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·O KarlströmL G Burman
Jun 18, 1998·The Journal of Antimicrobial Chemotherapy·J S Brazier
Oct 20, 1998·The Journal of Hospital Infection·G E Bignardi
Nov 26, 1999·The New England Journal of Medicine·S JohnsonD N Gerding
Feb 5, 2000·The Journal of Hospital Infection·M H Samore
Sep 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S JohnsonD N Gerding
Jan 11, 2001·The Journal of Antimicrobial Chemotherapy·J WiströmB Svenungsson
Feb 13, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I PoilaneA Collignon
Feb 24, 2001·Scandinavian Journal of Infectious Diseases·M OppenheimerE Holst
Oct 10, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B SvenungssonA Lundberg
Oct 27, 2001·The Journal of Antimicrobial Chemotherapy·J S BrazierM H Wilcox
Mar 27, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M J LeroiT Gottlieb
May 10, 2002·Journal of Gastroenterology and Hepatology·Sathaporn ManatsathitUNKNOWN Working Party of the Program Committ of the Bangkok World Congress of Gastroenterology 2002
May 23, 2002·Antimicrobial Agents and Chemotherapy·T PeláezE Bouza
Oct 19, 2002·International Journal of Antimicrobial Agents·Wafaa Y JamalV O Rotimi
Apr 22, 2004·Journal of Clinical Gastroenterology·Angel FernandezFrank Friedenberg
May 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel M MusherRichard J Hamill

❮ Previous
Next ❯

Citations

Apr 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jacques Pepin
May 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ed J Kuijper, Mark H Wilcox
Aug 12, 2008·The Journal of Antimicrobial Chemotherapy·Simon D BainesMark H Wilcox
Oct 30, 2012·The Journal of Antimicrobial Chemotherapy·Ines MouraPaola Mastrantonio
Mar 13, 2013·Antimicrobial Agents and Chemotherapy·Kevin A BrownDavid N Fisman
Nov 19, 2013·PloS One·Charles DarkohHerbert L DuPont
Mar 1, 2014·Iranian Red Crescent Medical Journal·Mehdi GoudarziMohammad Mehdi Aslani
Oct 2, 2013·Folia Microbiologica·Silvia CorbelliniCarlo Bonfanti
Apr 4, 2007·Digestive Diseases and Sciences·Rajaraman Durai
Oct 16, 2009·International Journal of Antimicrobial Agents·Haihui HuangCarl Erik Nord
Dec 23, 2008·International Journal of Antimicrobial Agents·Haihui HuangCarl Erik Nord
Apr 5, 2016·International Journal of Food Microbiology·S N ThitaramP J Fedorka-Cray
Nov 15, 2012·International Journal of Antimicrobial Agents·Danfeng DongYibing Peng
Jan 13, 2015·Infectious Disease Clinics of North America·Melinda M Soriano, Stuart Johnson
Sep 8, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T NorénM Unemo
Jan 24, 2015·Journal of Pharmacy Practice·Ryan M McCoyRyan B Dull
Mar 24, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Stuart H CohenUNKNOWN Infectious Diseases Society of America
Feb 10, 2018·International Journal of Microbiology·Eman N Abu-KhaderAsem A Shehabi
Apr 5, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jennifer Halsey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.